Ogorek Anthony Joseph’s Regeneron Pharmaceuticals REGN Stock Holding History

Ogorek Anthony Joseph’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$64K	Sell	103 -4	-4%	-$2.72K	0.02%	153
2026 Q1	$83K	Buy	107 +5	+5%	+$3.83K	0.02%	119
2025 Q4	$79K	Sell	102 -3	-3%	-$2.04K	0.02%	119
2025 Q3	$59K	Buy	105 +12	+13%	+$6.79K	0.02%	157
2025 Q2	$48K	Sell	93 -5	-5%	-$2.79K	0.01%	167
2025 Q1	$62K	Buy	98 +23	+31%	+$15.8K	0.02%	133
2024 Q4	$53K	Sell	75 -25	-25%	-$21K	0.02%	116
2024 Q3	$105K	Hold	100	–	–	0.04%	75
2024 Q2	$105K	Hold	100	–	–	0.04%	74
2024 Q1	$96K	Hold	100	–	–	0.03%	73
2023 Q4	$87K	Hold	100	–	–	0.03%	76
2023 Q3	$82K	Hold	100	–	–	0.03%	91
2023 Q2	$71K	Hold	100	–	–	0.03%	88
2023 Q1	$82K	Buy	+100	New	+$75.4K	0.03%	85

Other funds holding REGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Ogorek Anthony Joseph's REGN Position: Q2 2026 in Review

Ogorek Anthony Joseph reduced its Regeneron Pharmaceuticals (REGN) stake by 3.7% in Q2 2026, selling an estimated $2.72K and leaving 103 shares worth $64K. The position accounts for 0.02% of the portfolio, ranked #153.

Ogorek Anthony Joseph first reported a position in REGN in Q1 2023 and has held it in 14 quarters since. The position peaked at $105K in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Ogorek Anthony Joseph held 103 shares of Regeneron Pharmaceuticals worth $64K as of Q2 2026.
Ogorek Anthony Joseph sold 4 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.72K.
Regeneron Pharmaceuticals made up 0.02% of Ogorek Anthony Joseph's portfolio in Q2 2026, its #153 holding.
Ogorek Anthony Joseph first reported a position in Regeneron Pharmaceuticals in Q1 2023 and has held it in 14 quarters since.
Ogorek Anthony Joseph's Regeneron Pharmaceuticals position peaked at $105K in Q3 2024.
1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Ogorek Anthony Joseph's 13F filing for Q2 2026, filed 7 Aug 2026.